![]() | |
Names | |
---|---|
Preferred IUPAC name N-(4-Fluorophenyl)-N-(propan-2-yl)-2-{[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]oxy}acetamide | |
Other names Fluthiamide; Thiafluamide | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.127.787 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C14H13F4N3O2S | |
Molar mass | 363.33 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Flufenacet is an oxyacetanilide herbicide applied before crops have emerged. [1] It was registered for use in the United States in 1998 and the European Union in 2004. [2]
Flufenacet is related to the chloroacetamide class of herbicides and has the same mode of action through inhibiting the germination of seeds by inhibiting very long chain fatty acid synthesis. [3] [4]
In the model plant Arabidopsis thaliana it causes similar symptoms to the fiddlehead mutant. [5]
In temperate Europe, flufenacet is commonly used in cereal crops to control grass weeds such as black-grass (Alopecurus myosuroides) that have evolved resistance to other herbicides and is applied in combination with other herbicides including pendimethalin, diflufenican, flurtamone, metribuzin and aclonifen. [6] As of 2019 [update] in the United Kingdom, resistance to flufenacet had began to be found in black-grass and rye-grass. [7] As of 2022 [update] it was the most widely applied herbicide and third most widely applied pesticide in England, being used on 2.9 million hectares. [8]
Flufenacet and its metabolites can be classified as PFAS substances, or so-called "forever chemicals". They break down to produce trifluoroacetic acid (TFA), a persistent substance that pollutes groundwater. [9] [10]
In September 2024, the European Food Safety Authority has concluded that flufenacet is an endocrine disruptor of humans and wild mammals via the thyroid (T)-modality. [9] The active substance falls under the exclusion criteria of the Plant Protection Products Regulation. Re-authorisation of the active substance by the EU Commission is therefore no longer possible. The EU Commission will draw up a proposal for the non-authorisation of flufenacet, including withdrawal and sunset periods, which the EU member states are expected to vote on in spring 2025. [11] [12]
Flufenacet can be obtained by reacting equivalent amounts of 2-methylsulfonyl-5-trifluoromethyl-1,3,4-thiadiazole with 2-hydroxy[N-(4-fluoropheny)-N-isopropyl]acetamide in the presence of sodium hydroxide in acetone. [13]